CAD106
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for CAD106, covering 2020-02-11 to 2021-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease [Phase 2, Phase 3]